logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Drug Safety cover

Drug Safety

IF3.8
Papers3101
Citations6967
Journal Papers 7153
Publication Date
delete
Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024–July 4, 2025
deleteDrug Safety
IF3.8
delete2026-10-03
delete0
PREAI
deleteBrittney Romanson; Pedro L. Moro; Penelope Strid; Anne Hause; Erin Stroud; Paige L. Marquez; Bicheng Zhang; Carol Ennulat; Hannah Brown; John R. Su
deleteShare
deleteSave
Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New Zealand
deleteDrug Safety
IF3.8
delete2026-10-02
delete0
deleteOAAI
deleteXin Yi Lim; Shane Scahill; Sanyogita Ram; Joanne Barnes
deleteShare
deleteSave
The Value of Time-to-Onset for Signal Validation: Experience from the Reporting of COVID-19 Vaccines and Glomerular Diseases in VigiBase
deleteDrug Safety
IF3.8
delete2026-10-01
delete0
deleteOAAI
deleteAnnette Rudolph; Monica Tarapues; Oskar Gauffin; Qun-Ying Yue
deleteShare
deleteSave
Drug Brand Switching: A Regulatory Perspective
deleteDrug Safety
IF3.8
delete2026-10-01
delete0
deleteOAAI
deletePing Siu Kee; Paul K. L. Chin; Michael Tatley; Rhiannon Braund; Martin A. Kennedy; Simran D. S. Maggo
deleteShare
deleteSave
Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis
deleteDrug Safety
IF3.8
delete2026-09-22
delete0
PREAI
deleteThibault Viguier; Julien Bezin; Alex Hlavaty; Charles Khouri; Antoine Pariente
deleteShare
deleteSave
The WHO-ISoP Pharmacovigilance Curriculum: 2026 Update
deleteDrug Safety
IF3.8
delete2026-09-20
delete0
deleteOAAI
deleteJürgen Beckmann; Marco Tuccori; Priya Bahri; Francesco Salvo; Mónica Tarapués; Manal M. Younus; Hussain Al Ramimmy; Mayada Alkhakany; Thamir Alshammari; Beate Aurich; Nicole Baker; Madhava Balakrishnan; Ghita Benabdallah; Pernette Bourdillon Esteve; Ian Boyd; Siva Kumar Buddha; Gianmario Candore; Emiliano Cappello; Angela Caro-Rojas; Rebecca Chandler; Jerin Jose Cherian; Karen Cohen; Salvatore Crisafulli; Shelley Deeks; Jean-Christophe Delumeau; Moin Don; Joan Dsouza; Ernest D. Dzidzornu; Brian D. Edwards; I. Ralph Edwards; Jefman Efendi Marzuki HY; Albert Figueras; Mohammed I. Fouda; Ayako Fukushima; Giovanni Furlan; Georgy Genov; Gloria Giraldo; Michael Gold; Tarek Hammad; Kenneth Hartigan-Go; Maria Teresa Herdeiro; Richard Hill; Noha Iessa; Katarina Ilic; Sujeet Jain; EunMi Kim; Larissa Kopp; Veronique Kugener; Smaragda Lamprianou; Navinisha Lee; Marie Lindquist; Michaela Lucas; Viola Macolic Sarinic; Ishak Mansi; Ushma C. Mehta; Johanna C. Meyer; Joseph Mitchell; Maryam Naeem; Comfort Ogar; Ladi Owolabi; Jayesh Pandit; Lembit Rägo; Emanuel Raschi; Hadir Rostom; Mulugeta Russom; George T. Sabblah; Maribel Salas; Souad Skalli; Fumihito Takanashi; Michael Tatley; Gianluca Trifiro; Claudia Vaca; Florence van Hunsel; Eugène van Puijenbroek; Jessica Liliana Vargas-Neri; Ryan J. Walker; Xinyu Weng; Ian C. K. Wong; Qun-Ying Yue; Li Zhang; Omar Aimer; Shanthi N. Pal
deleteShare
deleteSave
A Text-Mining Algorithm for Identifying Drug Pairs Potentially Involved in Prescribing Cascades: Development and Internal Validation Within the Prescribing Inappropriateness Assessment (PINA) Digital Tool
deleteDrug Safety
IF3.8
delete2026-09-19
delete0
deleteOAAI
deleteMassimo Carollo; Anna Forti; Salvatore Crisafulli; Luca L’Abbate; Irene Cristini; Federica Soardo; Marilisa Giustina Stano; David Bellantuono; Davide Benetti; Riccardo Lora; Gianluca Trifirò
deleteShare
deleteSave
The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy
deleteDrug Safety
IF3.8
delete2026-09-17
delete0
PREAI
deleteManfred Hauben; Rave Harpaz; Robert Weber
deleteShare
deleteSave
Authors’ Reply to John Diaz-Decaro’s comment on: “Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta-analysis of Safety and Effectiveness”
deleteDrug Safety
IF3.8
delete2026-09-17
delete0
PREAI
deleteAgustín Ciapponi; Jamile Ballivian; Mabel Berrueta; Juan M. Sambade; Noelia Castellana; Ariel Bardach; Martin Brizuela; Julieta Caravario; Daniel Comande; Esteban Couto; Agustina Mazzoni; Edward Parker; Florencia Salva; Katharina Stegelmann; Xu Xiong; Andy Stergachis; Flor M. Munoz; Pierre Buekens
deleteShare
deleteSave
Interpreting Positive and Inverse Disproportionality Signals in Spontaneous Reporting Systems: A Claim-Strength Framework with Direction-Aware Evaluation
deleteDrug Safety
IF3.8
delete2026-09-17
delete0
deleteOAAI
deleteYoshihiro Uesawa
deleteShare
deleteSave
Comment on “Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta-analysis of Safety and Effectiveness”
deleteDrug Safety
IF3.8
delete2026-09-17
delete0
PREAI
deleteJohn Diaz-Decaro
deleteShare
deleteSave
Non-genetic Risk Factors for Allopurinol-Induced Severe Cutaneous Adverse Reaction (SCAR): A Systematic Review
deleteDrug Safety
IF3.8
delete2026-09-15
delete0
PREAI
deleteWei Leik Ng; Prawira Oka; Karleen Chong; Siok Fuang Liong; Rizawati Ramli; Winn Hui Han; Shin Shen Yong; Hooi Min Lim
deleteShare
deleteSave
Sodium Glucose Co-Transporter 2 Inhibitors and Ventricular Arrhythmias in Patients with Type 2 Diabetes: A Systematic Review of Observational Studies
deleteDrug Safety
IF3.8
delete2026-09-06
delete0
PREAI
deleteWang-Choi Tang; Wanning Wang; Antonios Douros; Oriana Hoi Yun Yu; Robert W. Platt; Kristian B. Filion
deleteShare
deleteSave
Challenges and Insights from the Mepolizumab Pregnancy Exposure Study
deleteDrug Safety
IF3.8
delete2026-09-03
delete0
PREAI
deleteKeele E. Wurst; Michael Schatz; Subramanya Kumar; Megan Delgado; Christina D. Chambers
deleteShare
deleteSave
Development and Validation of a Two-Stage NLP System Combining Rule-Based Extraction and LLM-Based Classification for Deprescribing Recommendations in Discharge Summaries
deleteDrug Safety
IF3.8
delete2026-09-03
delete0
deleteOAAI
deleteKenji Fujita; Marion Matheson; Bhavya Valecha; Sarah N. Hilmer
deleteShare
deleteSave
Esketamine Use and Attempted Suicide or Intentional Self-Harm Among Individuals with Treatment-Resistant Depression: A Retrospective Cohort Study
deleteDrug Safety
IF3.8
delete2026-09-02
delete0
PREAI
deleteYou Wang; Alexandra S. Storaci; G. Caleb Alexander; Jason B. Gibbons
deleteShare
deleteSave
ISoP MENA Chapter: Strategic Development and Future Directions Following a Decade of Strengthening Pharmacovigilance in the Middle East and North Africa
deleteDrug Safety
IF3.8
delete2026-09-02
delete0
PREAI
deleteHadir Rostom; Mohamed A. Elhawary; Mayada Alkhakany; Manal M. Younus; Thamir Alshammari; Felipe Villalobos; Omar Aimer
deleteShare
deleteSave
Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials
deleteDrug Safety
IF3.8
delete2026-09-02
delete0
PREAI
deleteAmeet Sarpatwari; Frazer A. Tessema; Mayookha Mitra-Majumdar; Su Been Lee; Heidi Zakoul; Beatrice L. Brown; Gita A. Toyserkani; Kate Heinrich Oswell; Cynthia LaCivita; Gerald J. Dal Pan; Steven Woloshin; Jerry Avorn; Aaron S. Kesselheim
deleteShare
deleteSave
Predictive Safety in the Era of Artificial Intelligence: Promises, Limits, and the Case for an Enterprise Lifecycle Evidence Ecosystem
deleteDrug Safety
IF3.8
delete2026-08-28
delete0
deleteOAAI
deleteTarek A. Hammad; Justine Rochon; Kate Gofman; Gianluca Trifirò; Andrew Bate
deleteShare
deleteSave
Artificial Intelligence in Pharmacovigilance: Guiding Principles from the CIOMS Working Group XIV
deleteDrug Safety
IF3.8
delete2026-08-26
delete0
deleteOAAI
deleteG. Niklas Norén; Julie Durand; Vijay Kara; Elizabeth MacEntee Pileggi; Hua Carroll; Sanna Hill; Manfred Hauben; Taxiarchis Botsis; Lembit Rägo
deleteShare
deleteSave